A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
| Autor: | Fuchs, C.S. *, Azevedo, S., Okusaka, T., Van Laethem, J.-L., Lipton, L.R., Riess, H., Szczylik, C., Moore, M.J., Peeters, M., Bodoky, G., Ikeda, M., Melichar, B., Nemecek, R., Ohkawa, S., Świeboda-Sadlej, A., Tjulandin, S.A., Van Cutsem, E., Loberg, R., Haddad, V., Gansert, J.L., Bach, B.A., Carrato, A. |
|---|---|
| Zdroj: | In Annals of Oncology May 2015 26(5):921-927 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|